Nuclear Medicine/Radiopharmaceuticals Market Report

RA01931

Nuclear Medicine/Radiopharmaceuticals Market, by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), Application (Diagnostic Applications): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01931

Pages: 240

Feb 2023

The global nuclear medicine/radiopharmaceuticals market is estimated to surpass $5,920.4 million by 2027, exhibiting a CAGR of 4.7% from 2020 to 2027.

WHAT DOES THE REPORT INCLUDE?

You can get a clear overview of the current market scenario along with future trends of the global nuclear medicine/radiopharmaceuticals market. The report will also provide you knowledge of various market dynamics and vital elements influencing the market. In the market dynamics section, the drivers and opportunities in the market contributing to the market growth are acknowledged. Besides, challenges and restraints that hold potential to hamper the market growth have also been mentioned in the report. Porter’s five forces analysis is delivered through the report which precisely highlights the effects of key forces on the global nuclear medicine/radiopharmaceuticals market.

The report offers estimations of market size and analyzes the global nuclear medicine/radiopharmaceuticals market for the forecast period by bifurcating the market in various segments. The report also includes elaborated geographical analysis of the market. Each segment entailed in the report is studied at regional and country level as well to get the overview of the market. The report has categorized the market into four major geographical regions including North America, Europe, Asia-Pacific, and LAMEA for a systematic study. These geographies are further sub-categorized into countries to cover the nuclear medicine/radiopharmaceuticals market scenario across respective regions.

Going further, the report highlights the competitive scenario of the global nuclear medicine/radiopharmaceuticals market. The key players operating in the global nuclear medicine/radiopharmaceuticals market are studied in the report to understand their current market position and competitive strengths in the industry. The report profiles 10 companies leading the industry. Moreover, the company profiles include various data-points such as company overview, company executives, recent financials of the company, major growth strategies advocated by company, new initiatives and advancements by company to sustain their position in the global nuclear medicine/radiopharmaceuticals market.

KEY BENEFITS OF THE REPORT

The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts

This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global nuclear medicine/radiopharmaceuticals market

The report maps the qualitative sway of various industry factors on market segments as well as geographies

The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the nuclear medicine/radiopharmaceuticals market

The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the nuclear medicine/radiopharmaceuticals market

KEY MARKET SEGMENTS

The global nuclear medicine/radiopharmaceuticals market is segmented as follows:

Type: Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes

Application: Diagnostic Applications

Region: North America, Europe, Asia Pacific, and LAMEA

This segment is further sub-segmented into the following regions:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

LEADING MARKET PLAYERS

The global nuclear medicine/radiopharmaceuticals market is expected to flourish with the active and strong presence of a large number of big companies. These market players focus upon the innovation and the expansion of product portfolios to acquire a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

The leading companies of the global XXX market include,

1. Cardinal Health

2. GE Healthcare

3. Curium

4. Lantheus Medical Imaging

5. Bayer AG

6. Bracco Imaging

7. Eczac

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Nuclear Medicine/Radiopharmaceuticals Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Nuclear Medicine/Radiopharmaceuticals Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Nuclear Medicine/Radiopharmaceuticals Market, By Application
- 5.1. Overview
- 5.2 Diagnostic Nuclear Medicine
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Therapeutic Nuclear Medicine
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Brachytherapy Isotopes
  - 5.4.1 Definition, key trends, growth factors, and opportunities
  - 5.4.2 Market size analysis, by region, 2020-2027
  - 5.4.3 Market share analysis, by country, 2020-2027
- 5.5 Research Dive Exclusive Insights
  - 5.5.1 Market attractiveness
  - 5.5.2 Competition heatmap
6. Nuclear Medicine/Radiopharmaceuticals Market, By Technology
- 6.1. Overview
- 6.2 Diagnostic Applications
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 Research Dive Exclusive Insights
  - 6.3.1 Market attractiveness
  - 6.3.2 Competition heatmap
7. Nuclear Medicine/Radiopharmaceuticals Market, By Region
- 7.1 North America
  - 7.1.1 U.S
    - 7.1.1.1 Market size analysis, By Application, 2020-2027
    - 7.1.1.2 Market size analysis, By Technology, 2020-2027
  - 7.1.2 Canada
    - 7.1.2.1 Market size analysis, By Application, 2020-2027
    - 7.1.2.2 Market size analysis, By Technology, 2020-2027
  - 7.1.3 Mexico
    - 7.1.3.1 Market size analysis, By Application, 2020-2027
    - 7.1.3.2 Market size analysis, By Technology, 2020-2027
  - 7.1.4 Research Dive Exclusive Insights
    - 7.1.4.1 Market attractiveness
    - 7.1.4.2 Competition heatmap
- 7.2 Europe
  - 7.2.1 Germany
    - 7.2.1.1 Market size analysis, By Application, 2020-2027
    - 7.2.1.2 Market size analysis, By Technology, 2020-2027
  - 7.2.2 UK
    - 7.2.2.1 Market size analysis, By Application, 2020-2027
    - 7.2.2.2 Market size analysis, By Technology, 2020-2027
  - 7.2.3 France
    - 7.2.3.1 Market size analysis, By Application, 2020-2027
    - 7.2.3.2 Market size analysis, By Technology, 2020-2027
  - 7.2.4 Spain
    - 7.2.4.1 Market size analysis, By Application, 2020-2027
    - 7.2.4.2 Market size analysis, By Technology, 2020-2027
  - 7.2.5 Italy
    - 7.2.5.1 Market size analysis, By Application, 2020-2027
    - 7.2.5.2 Market size analysis, By Technology, 2020-2027
  - 7.2.6 Rest of Europe
    - 7.2.6.1 Market size analysis, By Application, 2020-2027
    - 7.2.6.2 Market size analysis, By Technology, 2020-2027
  - 7.2.7 Research Dive Exclusive Insights
    - 7.2.7.1 Market attractiveness
    - 7.2.7.2 Competition heatmap
- 7.3 Asia-Pacific
  - 7.3.1 China
    - 7.3.1.1 Market size analysis, By Application, 2020-2027
    - 7.3.1.2 Market size analysis, By Technology, 2020-2027
  - 7.3.2 Japan
    - 7.3.2.1 Market size analysis, By Application, 2020-2027
    - 7.3.2.2 Market size analysis, By Technology, 2020-2027
  - 7.3.3 India
    - 7.3.3.1 Market size analysis, By Application, 2020-2027
    - 7.3.3.2 Market size analysis, By Technology, 2020-2027
  - 7.3.4 Australia
    - 7.3.4.1 Market size analysis, By Application, 2020-2027
    - 7.3.4.2 Market size analysis, By Technology, 2020-2027
  - 7.3.5 South Korea
    - 7.3.5.1 Market size analysis, By Application, 2020-2027
    - 7.3.5.2 Market size analysis, By Technology, 2020-2027
  - 7.3.6 Rest of Asia-Pacific
    - 7.3.6.1 Market size analysis, By Application, 2020-2027
    - 7.3.6.2 Market size analysis, By Technology, 2020-2027
  - 7.3.7 Research Dive Exclusive Insights
    - 7.3.7.1 Market attractiveness
    - 7.3.7.2 Competition heatmap
- 7.4 LAMEA
  - 7.4.1 Brazil
    - 7.4.1.1 Market size analysis, By Application, 2020-2027
    - 7.4.1.2 Market size analysis, By Technology, 2020-2027
  - 7.4.2 Saudi Arabia
    - 7.4.2.1 Market size analysis, By Application, 2020-2027
    - 7.4.2.2 Market size analysis, By Technology, 2020-2027
  - 7.4.3 UAE
    - 7.4.3.1 Market size analysis, By Application, 2020-2027
    - 7.4.3.2 Market size analysis, By Technology, 2020-2027
  - 7.4.4 South Africa
    - 7.4.4.1 Market size analysis, By Application, 2020-2027
    - 7.4.4.2 Market size analysis, By Technology, 2020-2027
  - 7.4.5 Rest of LAMEA
    - 7.4.5.1 Market size analysis, By Application, 2020-2027
    - 7.4.5.2 Market size analysis, By Technology, 2020-2027
  - 7.4.6 Research Dive Exclusive Insights
    - 7.4.6.1 Market attractiveness
    - 7.4.6.2 Competition heatmap
8. Competitive Landscape
- 8.1 Top winning strategies, 2020-2027
  - 8.1.1 By strategy
  - 8.1.2 By year
- 8.2 Strategic overview
- 8.3 Market share analysis, 2020-2027
9. Company Profiles
- 9.1 Cardinal Health
  - 9.1.1 Overview
  - 9.1.2 Business segments
  - 9.1.3 Product portfolio
  - 9.1.4 Financial performance
  - 9.1.5 Recent developments
  - 9.1.6 SWOT analysis
- 9.2 GE Healthcare
  - 9.2.1 Overview
  - 9.2.2 Business segments
  - 9.2.3 Product portfolio
  - 9.2.4 Financial performance
  - 9.2.5 Recent developments
  - 9.2.6 SWOT analysis
- 9.3 Curium
  - 9.3.1 Overview
  - 9.3.2 Business segments
  - 9.3.3 Product portfolio
  - 9.3.4 Financial performance
  - 9.3.5 Recent developments
  - 9.3.6 SWOT analysis
- 9.4 Lantheus Medical Imaging
  - 9.4.1 Overview
  - 9.4.2 Business segments
  - 9.4.3 Product portfolio
  - 9.4.4 Financial performance
  - 9.4.5 Recent developments
  - 9.4.6 SWOT analysis
- 9.5 Bayer AG
  - 9.5.1 Overview
  - 9.5.2 Business segments
  - 9.5.3 Product portfolio
  - 9.5.4 Financial performance
  - 9.5.5 Recent developments
  - 9.5.6 SWOT analysis
- 9.6 Bracco Imaging
  - 9.6.1 Overview
  - 9.6.2 Business segments
  - 9.6.3 Product portfolio
  - 9.6.4 Financial performance
  - 9.6.5 Recent developments
  - 9.6.6 SWOT analysis
- 9.7 Eczacýbaþý-Monrol Nuclear Products
  - 9.7.1 Overview
  - 9.7.2 Business segments
  - 9.7.3 Product portfolio
  - 9.7.4 Financial performance
  - 9.7.5 Recent developments
  - 9.7.6 SWOT analysis
- 9.8 Nordion
  - 9.8.1 Overview
  - 9.8.2 Business segments
  - 9.8.3 Product portfolio
  - 9.8.4 Financial performance
  - 9.8.5 Recent developments
  - 9.8.6 SWOT analysis
- 9.9 Advanced Accelerator Applications
  - 9.9.1 Overview
  - 9.9.2 Business segments
  - 9.9.3 Product portfolio
  - 9.9.4 Financial performance
  - 9.9.5 Recent developments
  - 9.9.6 SWOT analysis
- 9.10 NTP Radioisotopes
  - 9.10.1 Overview
  - 9.10.2 Business segments
  - 9.10.3 Product portfolio
  - 9.10.4 Financial performance
  - 9.10.5 Recent developments
  - 9.10.6 SWOT analysis

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Nuclear Medicine/Radiopharmaceuticals Market Report

Nuclear Medicine/Radiopharmaceuticals Market, by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), Application (Diagnostic Applications): Global Opportunity Analysis and Industry Forecast, 2020-2027

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Nuclear Medicine/Radiopharmaceuticals Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Nuclear Medicine/Radiopharmaceuticals Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Nuclear Medicine/Radiopharmaceuticals Market, By Application

5.1. Overview

5.2 Diagnostic Nuclear Medicine

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Therapeutic Nuclear Medicine

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Brachytherapy Isotopes

5.4.1 Definition, key trends, growth factors, and opportunities

5.4.2 Market size analysis, by region, 2020-2027

5.4.3 Market share analysis, by country, 2020-2027

5.5 Research Dive Exclusive Insights

5.5.1 Market attractiveness

5.5.2 Competition heatmap

6. Nuclear Medicine/Radiopharmaceuticals Market, By Technology

6.1. Overview

6.2 Diagnostic Applications

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 Research Dive Exclusive Insights

6.3.1 Market attractiveness

6.3.2 Competition heatmap

7. Nuclear Medicine/Radiopharmaceuticals Market, By Region

7.1 North America

7.1.1 U.S

7.1.1.1 Market size analysis, By Application, 2020-2027

7.1.1.2 Market size analysis, By Technology, 2020-2027

7.1.2 Canada

7.1.2.1 Market size analysis, By Application, 2020-2027

7.1.2.2 Market size analysis, By Technology, 2020-2027

7.1.3 Mexico